The study was carried out to determine the concentrations of cefodizime (single 2-g intravenous [i.v.] dose) and ceftriaxone (single 2-g i.v. dose) in the sera and bones of 42 patients (18 women and 24 men) undergoing hip arthroplasty. The concentrations of cefodizime and ceftriaxone in cancellous and cortical bone appear to be related to the free levels in serum but not to the total levels in serum, so the concentrations of cephalosporins in bone must be compared with the free concentrations in serum. Both drugs diffuse well into bone, with concentrations exceeding the MIC at which 90% of the major pathogenic infecting organisms are inhibited.
The prime objective of antimicrobial prophylaxis is to prevent the growth of an invading microorganism by delivering an adequate amount of the drug to the operating site. The choice of antimicrobial agent depends on the activity of a drug against the suspected pathogens and on the ability of the drug to reach and maintain effective concentrations at infection sites. The active concentrations of antibiotics at the site of infections is one of the main factors involved in a positive clinical response (13, 16) . During operations such as hip arthroplasty, antibiotic concentrations should be maximal throughout the operation, but particularly at the time of bone removal and prosthesis implantation (4, 7) . To avoid further injections, an antibiotic with a long half-life (t 1/2 ) can be used (8) .
Cefodizime is a new broad-spectrum, parenterally administered cephalosporin characterized by a 2-amino-5-thiazolylmethoxyimino group at position 7 conferring a high level of antibacterial activity, especially against gram-negative bacteria, and stability to beta-lactamase hydrolysis, while at position 3 a mercaptothiazolyl-substituted (methyl and acetoxy) group leads to a long apparent elimination t 1/2 (t 1/2 3 to 4 h in healthy subjects). The level of protein binding is about 70% (1, 5, 15) .
Ceftriaxone is a broad-spectrum, parenterally administered cephalosporin characterized by high levels of antibacterial activity, especially against gram-negative bacteria, and stability to beta-lactamase hydrolysis (14, 15) . It has been used for a long time for therapy as well as prophylaxis. This drug has a long apparent elimination t 1/2 (6 to 8 h in healthy subjects). The level of protein binding is about 95% (22) .
In the study described here we determined the concentrations of cefodizime and ceftriaxone in the sera and bones of patients undergoing hip arthroplasty.
Since the level of protein binding can influence drug distribution (19) , total and free concentrations of cefodizime and ceftriaxone were measured in blood collected from the operative site during the operation and from the drainage catheter over the next 24 h.
Forty-two patients (18 women and 24 men) with normal renal function were admitted to hospital for routine hip arthroplasty and were enrolled in the study. The median age was 66 years (age range, 60 to 71 years). The patients were randomly treated with cefodizime (22 patients) or ceftriaxone (20 patients) as prophylaxis. Two grams of the respective antibiotic was infused intravenously (i.v.) over 30 min to all patients at different times before surgery. The study was approved by the local ethics committee, and informed consent was obtained from each patient.
During surgery, a sample of blood from the surgical field was carefully collected, without contamination of irrigation or periosteal fluids, at the time of removal of the femoral head, and the time after the injection of antibiotics (exposure time) was noted. The blood specimen and the femoral head were immediately sent to the laboratory, where the serum was separated, and the separated serum and bone were stored at Ϫ70°C until the samples were assayed for antibiotic concentrations. Samples of blood from the drainage tube were collected for 24 h after surgery. No irrigations were performed during sample collections.
The bone samples were cleaned free of adhering tissue and were rinsed in phosphate buffer (pH 7.0). Cancellous bone was separated from compact bone and was crushed into small pieces, which were weighed, frozen, pulverized, and dissolved with phosphate buffer, and the total volume was measured. The bone pieces were shaken at 4°C for 5 h, and the supernatant was processed for assay of the antibiotic concentration. Serum separated from cells was assayed as described below. The final concentrations in bone were corrected for contaminating blood by colorimetric assay of the hemoglobin concentration.
The free fractions of the two antibiotics were obtained by ultrafiltration of serum by using the Centrifree micropartition system (Amicon Division, W. R. Grace & Co., Beverly, Mass.). The free and total concentrations of the tested antibiotics in serum and bone tissues were determined in duplicate by highperformance liquid chromatography (HPLC) by the method described by Chan et al. (3) . The method has been validated for its linearity, specificity, precision, and accuracy. Standard solutions were made up in drug-free human serum and phosphate buffer at concentrations ranging from 0.01 to 50 mg/liter. The HPLC system consisted of a Shimadzu liquid chromato-graph with a variable-wavelength UV detector (SPD 6 A), LC-9A pumps, autosampler (SIL 9A), and a reverse-phase column (C 18 Spherisorb). Antibiotic levels were evaluated by comparison of peak area ratios with standard curves, which were linear over a range of 0.05 to 25 mg/liter for both serum and bone tissues. Inter-and intra-assay coefficients of variation were 4.8 and 5.2, respectively, for serum and 5.1 and 6.0, respectively, for bone tissues. Results are presented as means Ϯ standard deviations. The two-tailed Student t test was used to detect significant differences in pharmacokinetics. Knowledge of the unbound and total concentrations of the drugs allowed us to calculate the extent of protein binding.
The mean concentrations of cefodizime and ceftriaxone in serum and bone are presented in Fig. 1 and 2 , respectively. Results for individual patients varied, but there was a general rise in the levels in bone toward maximum observed concentrations of cefodizime of 13.42 and 24.4 mg/kg of body weight in cortical and cancellous bone, respectively, 2.5 h after antibiotic administration. The corresponding maximum observed concentrations of ceftriaxone were 10.7 and 19.4 mg/kg, respectively.
The mean maximum concentrations in serum were observed in the first 2.5 h. The total concentrations of cefodizime and ceftriaxone were 121 and 146 mg/liter, respectively, and the free concentrations were 17.6 and 30.42 mg/liter, respectively. All concentrations in serum followed this pattern. No significant side effects were noted in any of the patients, and no infections occurred in the immediate postoperative follow-up period.
Evaluation of the role of antimicrobial agents in the success or failure of prophylaxis for infection during surgery involves a discussion of both the pharmacokinetic and the pharmacodynamic properties of particular agents. A main concern in surgical prophylaxis is the relation between the respective time courses of the antibiotic concentrations in serum and in tissue (2, 16) . Several problems arise with both the measurement and the interpretation of drug concentrations in tissues, and the results of this approach are still controversial (9, 10, 17) . However, knowledge of the numerous factors influencing the penetration of an antibiotic into a tissue and the characteristics of the relative distribution of the antibiotic between the compartments inside the tissue, i.e., the vascular, interstitial, and intracellular spaces, could allow for the creation of a valuable approach to solving this problem.
Antibiotic concentrations in bone are governed by the same factors that determine the concentrations in serum and tissues: absorption, distribution, biotransformation, and elimination. Nevertheless, it is difficult to measure antibiotic concentrations in bone, and the effects of protein binding and bone pathology are not well known.
Drug concentrations in tissues or fluids are directly proportional to the surface area available for diffusion and are inversely proportional to the volume of fluid at the infection site (16, 17) . Cancellous bone tissue has a rich capillary bed and a relatively small volume of interstitial fluid. Antibiotics would readily diffuse across the large capillary surface area and produce concentrations in the interstitial fluid of the cancellous bone that were very similar to those in the serum. The diffusion of antibiotics into cortical bone occurs exclusively through the bone marrow or periosteal circulation. No antibiotic has been detected in the femoral heads of patients with fractured necks of the femur (12) .
In this study the difference between antibiotic levels in cancellous and cortical bone samples can be accounted for by the differences in blood flow, and hence the levels of antibiotic penetration, and the different proportions of organic and inorganic bone.
The levels of cefodizime and ceftriaxone in cancellous and cortical bone in this study were dramatically lower than the total levels in serum, while they appeared comparable to the free levels in serum. It has been shown that the diffusion of different antibiotics into the extravascular fluids is influenced by the extent of protein binding if levels in tissue are compared to the total levels in serum. Minimal differences have been found when the levels in fluid have been compared to the free levels in serum, especially for beta-lactam agents eliminated predominantly by glomerular filtration (11, 16, 18) .
In this study the free levels of cephalosporins in serum were equal to the levels in bone. The concentrations of antibiotics in interstitial tissue fluid were equal to the free concentrations in serum, which is perfectly adequate in predicting efficacy, although the differences in bone pathology are not well known. Moreover, the concentrations of free drugs in serum are valuable predictors of the time course of unbound drug in interstitial fluid, where the bacteria are generally located. Pharmacodynamic studies of persistent growth suppression and bactericidal activity predict that the period during which the free drug concentration exceeds the MIC is an important parameter of the efficacies of beta-lactam antibiotics (6) . Thus, the goal of prophylaxis with beta-lactams could be to provide levels of free drug above the MIC for the whole surgical period. Both drugs dosed i.v. as single 2-g doses for patients undergoing hip arthroplasty gave at least 8 h of exposure (an exposure time at which the concentration was greater than the MIC for most pathogens, e.g., methicillin-sensitive Staphylococcus aureus members of the family enterobacteriaceae, and streptococci [14, 15] ) at the surgical site. This suggests that 
